เอทิลีนออกไซด์ (EO Or EtO) Residuals After Sterilization

เอทิลีนออกไซด์ (EO Or EtO) Residuals After Sterilization

While เอทิลีนออกไซด์ (อีโอ) การทำหมัน is the gold standard for medical device compatibility, the potential for chemical residuals post-processing is a critical safety concern. Manufacturers must ensure that all products adhere to ไอเอสโอ 10993-7 (AAMI 10993-7) standards to protect patients from potential toxicity.

Types of Residual Substances

During and after the EO sterilization process, three primary residues may be present based on the chemical interactions within the chamber or packaging:

1. เอทิลีนออกไซด์ (อีโอ) The primary sterilant gas that may remain absorbed in the device material or packaging.
2. Ethylene Chlorohydrin (ECH) Formation: อีโอ + Free Chloride Ions A toxic byproduct often formed when EO reacts with materials containing chlorine or PVC.
3. Ethylene Glycol (EG) Formation: อีโอ + Water (H2O) Formed when residual gas reacts with moisture during the cycle or aeration.

Standard Limits (AAMI 10993-7)

The permitted limits for Ethylene Oxide residuals depend on the duration and type of patient contact:

หมวดหมู่ Contact Duration Limit Requirement
Limited Use < 24 ชั่วโมง Strict limits for acute exposure
Prolonged Use 24 Hours to 30 Days Average daily dose limits applied
Permanent Use > 30 Days Most stringent lifetime dose limits

Understanding Tolerable Contact Limit (TCL)

Devices with direct surface contact or implants must also pass the Tolerable Contact Limit (TCL). This metric prevents localized skin or tissue irritation caused by the release of EO or ECH. The TCL is calculated by analyzing the device’s total surface area against recorded residual levels.

How BOCON Helps You Meet ISO 10993-7

โบคอน เครื่องฆ่าเชื้อ ETO ซีรีส์ BCS feature advanced integrated aeration systems. By combining heated aeration with high-efficiency vacuum pulses, our equipment significantly accelerates the removal of Ethylene Oxide residuals. This ensures your medical devices reach safe TCL levels faster, reducing lead times and ensuring total compliance with FDA and AAMI standards.

แสดงความคิดเห็น

ที่อยู่อีเมลของคุณจะไม่ถูกเผยแพร่. ช่องที่ต้องกรอกถูกทำเครื่องหมายไว้ *